At Synamics Therapeutics, we redefine drug discovery by staying ahead of cancer's evolution. Our groundbreaking platform harnesses the power of advanced AI to model and predict drug resistance. By designing compouds that preemptively overcome resistance, we ensure their prolonged effectiveness, even as tumors evolve.